To better understand the role complex tumor-host interactions play in tumor growth, researchers have developed a cellular automation model for tumor growth in heterogeneous microenvironments. Cancer ...

Cellular Origins and Fresenius Kabi, an operating company of Fresenius, announces they have signed a development agreement that leverages each company’s expertise in cell and gene therapies (CGTs).

Fresenius Kabi and Cellular Origins have announced a partnership to advance the field of cell and gene therapy (CGT) by automating the manufacturing process. Fresenius Kabi's cell therapy processing ...

Partnership to develop and implement Cellular Origins' robotic platform Constellation for universal automation of CGT manufacturing at CGT Catapult's Stevenage Manufacturing Innovation Centre Cellular ...

Cell culture and cellular applications have been and continue to be essential to medical and biological research. By automating these assays, researchers can reduce their time at the bench while ...

Cellular Origins and Fresenius Kabi, an operating company of Fresenius, announce today they have signed a development agreement that leverages each company’s expertise in cell and gene therapies (CGTs ...

Smart Manufacturing Cellular IoT Connectivity to Generate $4.9 billion in Revenue by 2028 as Automation & Maintenance Drive Investments in Digital A new report from Kaleido Intelligence, a leading ...

Cellular Origins, a TTP Company focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies (CGTs), and the Cell and Gene Therapy Catapult (CGT Catapult), an ...

(Nanowerk News) Researchers from the Singapore University of Technology and Design (SUTD) have designed a novel computational model that accurately predicts the properties of photonics materials, ...